Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Background
- Randomised controlled trials
- The Lidcombe program
- The Lidcombe program: results
- The Lidcombe program: overview
- The Lidcombe program: telepractice
- The Lidcombe program: groups
- The Lidcombe program: two stages
- The Lidcombe program: two components
- The Lidcombe program: ending stage 1
- The Lidcombe program: measurement
- The Lidcombe program: severity rating
- The Lidcombe program: verbal contingencies
- The Lidcombe program: five verbal contingencies
- Restart-DCM treatment: overview
- Restart-DCM treatment
- Restart-DCM treatment components
- Restart-DCM treatment: randomised trial
- The Lidcombe program: pros and cons
- Restart-DCM treatment: pros and cons
- The future
Topics Covered
- Treatment of stuttering during the preschool years
- Why treat early stuttering?
- Two different types of treatment
- Clinical trials
- Advantages and disadvantages of two types of treatment
- The future for the field
Talk Citation
Onslow, M. (2018, January 31). Treatment of stuttering during the pre-school years [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/NTVP1898.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Mark Onslow has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Speech Dysfluency
Transcript
Please wait while the transcript is being prepared...
0:00
During this presentation, I'll talk about treatment of stuttering during
the pre-schooler years and I'll talk about two ways that treatment can be done.
0:12
First of all, why treat early stuttering?
By early stuttering I mean stuttering when
children are during the preschool years of life,
younger than six years.
The first reason that it's important to treat stuttering that age is that if
children become any older the disorder starts to become intractable.
So the important thing is to treat stuttering as soon as it begins.
And we have the best chance of a clinically favorable outcome.
It's also the best time to treat stuttering because when you
treat early stuttering you need parents to do the treatment,
you can't do the treatment in a speech pathology clinic.
And at that time of life,
parents have most access to their children before they get to school.
And finally it's important to treat
stuttering very early in life and get it under clinical control,
because if an adult goes on to have
chronic stuttering throughout life it has a serious impact on quality of life.
There's an increased chance of having
a mental health disorder relating to social anxiety.
You might not be able to change the job that you want to
achieve because it's a job that involves talking.
1:28
So that being said,
there are two types of treatment that have been shown to
be effective in randomized controlled trials.
The first of the treatment for early stuttering has been shown to be
effective in such trials is what's called an operant treatment.
I'll explain that later.
And that is known as The Lidcombe program.
The other type of treatment is not as a multifactorial treatment that I'll
Explain in detail later and that's known as the RESTART-DCM treatment.
First of all, the Lidcombe Program is a behavioural treatment.